CME · Cme Group Inc.
Price & Indicators
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Financial Data & Stock Exchanges — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CME
this stock
Cme Group Inc.
|
$103.32B | +4.9% | +6.4% | 24.4 | 1.4% |
|
SPGI
S&P Global Inc.
|
$138.57B | — | +7.1% | 29.6 | 2.4% |
|
ICE
Intercontinental Exchange, Inc.
|
$89.60B | -1.5% | -2.1% | 22.5 | 1.4% |
|
MCO
Moodys Corp /De/
|
$85.68B | -3.2% | +16.6% | 31.4 | 1.5% |
|
LSEGY
London Stock Exchange Group plc
|
$57.65B | -2.5% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CME | +3.3% | +9.1% | -5.6% | +0.3% | +4.9% |
| SPY | -0.5% | -1.2% | +12.6% | -0.7% | +11.7% |
| vs SPY | +3.8% | +10.3% | -18.2% | +1.0% | -6.8% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.